Chai Discovery · Series B
Engineering better molecules using artificial intelligence for drug-like antibody design against challenging targets with atomic precision.
Amount
$130M
Round
Series B
Valuation
$1.3B
Announced
Dec 2025
Investors
Lead investor
Notes
General Catalyst / Oak HC/FT led. OpenAI-backed. Unicorn.
Other Chai Discovery rounds
| Date | Round | Amount | |
|---|---|---|---|
| Aug 2025 | Series A | $70M | Details → |